Home » Topics » BioWorld Science

BioWorld Science
RSS

New one-hour H. pylori diagnostic tool now available to Japanese health care specialists

Nov. 21, 1996

Spanish investigators discover novel antihypertensive agent

Nov. 21, 1996

Chiesi reports pharmacological profile of CHF-2363

Nov. 21, 1996

New market introduction for dorzolamide

Nov. 21, 1996

Merck & Co. launches Hyzaar in France

Nov. 21, 1996

Potent and selective PAF antagonist from Uriach

Nov. 21, 1996

French market introduction for Epivir

Nov. 21, 1996

Kissei begins overseas development of BPH treatment agent

Nov. 21, 1996

Otsuka discloses inhibitor of TNF-alpha production

Nov. 21, 1996

Anti-H. pylori compounds from Fujisawa

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...